Deutsch Contact Drug Products Custom Development & Manufacturing Portfolio AMP Alliance Medical Products a Siegfried Company Drug Substance Custom Development & Manufacturing Portfolio Competences Compliance Technology & Capabilities Services About us Investor Relations & Media Corporate Responsibility Jobs/Career Expect more with Siegfried as your preferred partner Bringing together our long-standing pharma and chemical heritage, we offer as an integrated partner benefit to our customers with more synergy, expertise and value. Explore more about how our broad range of custom development services, drug substance & drug product manufacturing capabilities, together with our existing product portfolio may help you achieve greater value. October 02, 2015 Siegfried successfully places public hybrid bond (SIX/SFZN) Siegfried Holding AG today successfully placed a subordinated public hybrid bond in the amount of CHF 100 million. The ... Read more » September 30, 2015 Successful acquisition of three BASF sites (SIX/SFZN) Siegfried and BASF concluded the implementation of the agreements on 30 September 2015. Siegfried has thereby acquired ... Read more » September 30, 2015 Siegfried issues hybrid convertible bond with RAG-Stiftung Beteiligungsgesellschaft mbH (SIX: SFZN) As announced in May 2015, RAG-Stiftung Beteiligungsgesellschaft mbH based in Essen, Germany, will participate in a ... Read more » Company movie Stock Quote (SFZN) > Stock Quote at Swissquote AMP Alliance Medical Products > Link to AMP Upcoming Events > Publication of Half-Year Results 2015: 19 August 2015 Topical > View company presentation Hameln Pharma > Media and Analysts' Conference 2015 SitemapRSS FeedsDisclaimer